Publication Topic

Anyangwe N, Fitzpatrick S, Flannery B, Mattia A, Schaefer H, Tyler T, Whiteside C. Use of dog studies in US FDA’s safety assessments for food additives and color additives. Abstract 2781, Society of Toxicology 58^th Annual Meeting, Baltimore, MD, March 2019.

Wikoff D. Rigor and resources for systematic reviews in toxicology: Case study applications in food safety, consumer product safety, and environmental health risk assessment. Presented at Society of Toxicology 58th Annual Meeting, Baltimore, MD, March 2019.

Sanz F, Pognan F, Steger-Hartmann T, Díaz C, Cases M, Pastor M, Marc P,…, Greene N, et al. 2017. Legacy data sharing to improve drug safety assessment: The eTOX project. Nat Rev Drug Discov 6(12):811-812; doi: 10.1038/nrd.2017.177. PMID: 29026211.

Meddings J, Reichert H, Green MT, Safdar N, Krein SL, Olmsted RN, Watson SR, Edson B, et al. 2017. Evaluation of the association between catheter‐associated infections and measures of safety culture: Results of two national collaboratives. BMJ Qual Saf 26(3):226-235; doi: 10.1136/bmjqs-2015-005012. PMID: 27222593.

Worth A, Patlewicz G. 2016. Integrated approaches to testing and assessment. Adv Exp Med Biol 856:317-342; doi: 10.1007/978-3-319-33826-2_13. PMID: 27671729.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and efficacy/effectiveness of 2nd-line treatments in Immune Thrombocytopenia (ITP): A systematic review of the literature. Presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, August 2016.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and efficacy/effectiveness of second-line treatments in patients with Immune Thrombocytopenia: A systematic review of the literature. Presented at the 21st Congress of the European Hematology Association, Copenhagen, Denmark, June 2016.

Cetin K, Callaghan F, Fryzek JP, Bylsma LC, Bezold C, Mehta B. Safety and efficacy/effectiveness of second-line treatments in patients with Immune Thrombocytopenia: A systematic review of the literature. Presented at the Thrombosis & Hemostasis Summit of North America, Chicago, IL, April 2016

Shah F, Leung L, Barton HA, Will Y, Rodrigues AD, Greene N, Aleo MD. 2015. Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays. Toxicol Sci 147(2):500-14; doi: 10.1093/toxsci/kfv152. PMID: 26206150.

Bottomley A, Prior H, Cordes J. Global cross-company data-sharing on the housing of non-rodents during the recording of cardiovascular telemetry data on safety pharmacology and toxicology studies. Poster presented at Safety Pharmacology Society, Prague, September 2015.

Barat S, Robison TW. Information and report formats to facilitate safety qualifications. USP/PQRI/FDA Annual Meeting, 2014/2013.

Robison TW, Barat SA. Information and report formats to facilitate safety qualifications suitability and compatibility for packaging and delivery systems. Workshop Co- sponsored by USP and PQRI, USP Meetings Center, Rockville, Maryland, April 28, 2014.

Choksi NY, Allen DG, Inhof CJ, Truax JF, Tice RR, Stokes WS. Performance of BCOP, IRE, ICE, and HET-CAM in detecting substances that induce severe irritation and irreversible ocular damage. Presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.

Cher DJ, Mrad RJ, Kelsh MA. 1999. Cellular telephone use and fatal traffic collisions: A commentary. Accid Anal Prev 31(5):599; doi: 10.1016/s0001-4575(99)00003-2. PMID: 10440557.